Welcome to Kidney Cancer Care

Welcome to the McMaster University - St. Joseph’s Healthcare Kidney Cancer Centre of Excellence (KCCE) website. This is a patient-oriented portal providing information and links regarding the cutting edge management of kidney cancer. Here you will find up-to-date information about kidney cancer and its treatment, recent advances in management, current clinical research information, and links to our basic science research program. We hope you find this website informative and useful and we welcome your feedback.

Anil Kapoor, MD, FRCSC
Director
McMaster – SJH Kidney Cancer Centre of Excellence (KCCE)

Get the Flash Player to see this player.

What’s new in Kidney Cancer Care

Neoadjuvant VEGF-Targeted Therapy in Renal Cell Carcinoma

Thursday, November 19, 2009
Recent therapeutic advances in metastatic renal cell carcinoma (RCC) have included agents targeted against vascular endothelial growth factor (VEGF). The agents, which target circulating VEGF ligand (e.g., bevacizumab) or the tyrosine kinase portion of the VEGF receptor (e.g., sunitinib, sorafenib), have dramatically altered the therapeutic landscape of this disease.

Votrient (pazopanib) Approved by Health Canada for the Treatment of Renal Cell Carcinoma

Wednesday, June 16, 2010
Health Canada has approved Votrient (pazopanib) for metastatic renal cell carcinoma.

Torisel Approved in Ontario

Friday, June 4, 2010
Effective June 14, 2010 Torisel will be funded in Ontario under the Ministry of Health